Japan · Delayed Price · Currency is JPY Towa Pharmaceutical Company Description
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan.
It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products.
It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes.
The company was founded in 1951 and is headquartered in Osaka, Japan.
| Country | Japan |
| Founded | 1951 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,788 |
| CEO | Itsuro Yoshida |
Contact Details
Address: 2-11, Shinbashi-cho Osaka, 571-8580 Japan | |
| Phone | 81 6 6900 9100 |
| Website | towayakuhin.co.jp |
Stock Details
| Ticker Symbol | 4553 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3623150004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Itsuro Yoshida | Chief Executive Officer |
| Shiro Hatagami | Chief Financial Officer |